Vanessa Slowey joins Over the Counter to explore the growing emergence of AI, automation, and pharmacy technology, providing a nuanced discussion surrounding the future of pharmacist-led care.

Thomas Lew, MD, ABIM, Molly O’Shea, MD, FAAP, and Jesse Goodman, MD, MPH, join Over the Counter to discuss ongoing developments regarding change in federal vaccine guidance and its impact on measles outbreaks across the US.

Kenzie Hohman, PharmD, and Scott Stoll join Over the Counter to discuss the power of pharmacy advocacy in driving the profession forward and ensuring business sustainability in the future.

Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, from Harps Food Stores, join Over the Counter to discuss the pharmacist's prescribing authority, real-world proof of why it must expand, and the focus on putting patients back at the center of care.

Rick Couldry, MS/HSPA, joins Over the Counter to discuss the industry's push to cloud-based pharmacy software and how this digital transformation is revolutionizing pharmacy practice and patient safety in real time.

Rae McMahan joins Over the Counter to discuss recent regulatory action involving CVS Caremark and the Federal Trade Commission, exploring what the collection of PBM reform efforts means for the greater pharmacy industry moving forward.

Duane Jones, BS Pharm, joins Over the Counter to discuss the growing evidence of nonopioid therapies for pain management as well as the improved outcomes stemming from the Johns Hopkins Perioperative Pain Program.

Sharon Blank, CEO of Language Scientific and RxTran, joins Over the Counter to discuss the potential dangers of language barriers in medication adherence and how pharmacists can use technology to overcome these barriers.

Richard Dion, PharmD, joins Over the Counter to discuss the emerging prominence of opioid stewardship in health systems' pain management programs and how the necessary role of pharmacists is making a true difference for patients.

Jay Bregman, founder and CEO of Andel, joins Over the Counter to discuss the Medicare GLP-1 Bridge Program and what pharmacists and their patients can expect from the initiative as it rolls out in early July 2026 and beyond.